Evidence map›Paper›PMID 15744743›Full record

ArticleJournal of neuroscience research2005

N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.

Daming Zhu, Xuan Wu, Kenneth I Strauss, Robert H Lipsky, Zehra Qureshi, Artin Terhakopian, Antonello Novelli, Krishna Banaudha, Ann M Marini

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Symptomatologic pathomechanism ofEncephalitis (Seoul, Korea) · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Daming ZhuDepartment of Neurology and Neuroscience, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA.
Xuan Wu
Kenneth I Strauss
Robert H Lipsky
Zehra Qureshi
Artin Terhakopian
Antonello Novelli
Krishna Banaudha
Ann M Marini
Uniformed Services University of the Health Sciences · USNational Institutes of Health · USUniversidad de Oviedo · ESUniversity of Cincinnati Medical Center · US

Funding

ABERRANT REGULATION OF COX2 AFTER TRAUMATIC BRAIN INJURYR01NS038654 · NINDS · UNIVERSITY OF CINCINNATI · PI STRAUSS, KENNETH I · 2000 to 2003
$1.1M
Molecular Genetics Of Glutamate FunctionZ01AA000325 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LIPSKY, ROBERT H · 2001 to 2008
$1.0M
NINDS NIH HHS R01 NS038654
6 · The paper itself

Abstract

N-Methyl-D-aspartate (NMDA) at a subtoxic concentration (100 microM) promotes neuronal survival against glutamate-mediated excitotoxicity via a brain-derived neurotrophic factor (BDNF) autocrine loop in cultured cerebellar granule cells. The signal transduction mechanism(s) underlying NMDA neuroprotection, however, remains elusive. The mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3-K) pathways alter gene expression and are involved in synaptic plasticity and neuronal survival. This study tested whether neuroprotective activation of NMDA receptors, together with TrkB receptors, coactivated the MAPK or PI3-K pathways to protect rat cerebellar neurons. NMDA receptor activation caused a concentration- and time-dependent activation of MAPK lasting 24 hr. This activation was blocked by the NMDA receptor antagonist MK-801 but was attenuated only partially by the tyrosine kinase inhibitor k252a, suggesting that activation of both NMDA and TrkB receptors are required for maximal neuroprotection. The MAPK kinase (MEK) inhibitor U0126 (10 microM) partially blocked NMDA neuroprotection, whereas LY294002, a selective inhibitor of the PI3-K pathway, did not affect the neuroprotective activity of NMDA. Glutamate excitotoxicity decreased bcl-2, bcl-X(L), and bax mRNA levels,. NMDA increases Bcl-2 and Bcl-X(L) protein levels and decreases Bax protein levels. NMDA and TrkB receptor activation thus converge on the extracellular signal-regulated kinase (ERK) 1/2 signaling pathway to protect neurons against glutamate-mediated excitotoxicity. By increasing antiapoptotic proteins of the Bcl-2 family, NMDA receptor activation may also promote neuronal survival by preventing apoptosis.

Indexed as

Animalsbcl-2-Associated X Proteinbcl-X ProteinBlotting, WesternButadienesCarbazolesChromonesEnzyme ActivationEnzyme InhibitorsExcitatory Amino Acid AntagonistsExtracellular Signal-Regulated MAP KinasesGene ExpressionGlutamic AcidIndole AlkaloidsMitogen-Activated Protein Kinase KinasesMorpholines2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBax protein, ratbcl-2-Associated X ProteinBcl2l1 protein, ratbcl-X ProteinButadienesCarbazolesChromonesEnzyme InhibitorsExcitatory Amino Acid AntagonistsExtracellular Signal-Regulated MAP KinasesGlutamic AcidIndole AlkaloidsMitogen-Activated Protein Kinase KinasesMorpholinesNeuroprotective AgentsNitrilesN-MethylaspartateProto-Oncogene Proteins c-bcl-2Receptor, trkBRNA, Messengerstaurosporine aglyconeU 0126

Identifiers

PMID15744743
PMCPMC2855499
OpenAlexW2079966712

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.